Wang, L., Dang, Q., Yuan, Y., Yunjian, H., Zhou, J., Yang, S., Sun, M., Gao, S., Jia, R., Yuan, L., Zhao, L., Yang, M., Zhang, Y., Zhao, J., Hou, X., Yu, H., Li, J., Wang, Q., Zhu, J., Yu, J. (2026). A multicenter, randomized phase 2 study evaluating the efficacy and safety of HLX43 (an anti-PD-L1 ADC) in recurrent/metastatic esophageal squamous cell carcinoma.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.364